دانلود کتاب Advances in Dementia Research

فهرست مطالب :

Front Matter....Pages I-VIII
White matter changes: the clinical consequences in the aging population....Pages 1-8
Longitudinal change of white matter abnormalities....Pages 9-14
Genetic aspects of microangiopathy-related cerebral damage....Pages 15-21
Research criteria for subcortical vascular dementia in clinical trials....Pages 23-30
How can cerebral infarcts and hemorrhages lead to dementia?....Pages 31-36
Vascular aspects in Alzheimer’s disease....Pages 37-43
Novel imaging technologies in the assessment of cerebral ageing and vascular dementia....Pages 45-52
Alzheimer disease and neuroinflammation....Pages 53-57
The immunological microenvironment in the CNS: implications on neuronal cell death and survival....Pages 59-68
Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous system....Pages 69-80
Cytokines in CNS disorders: neurotoxicity versus neuroprotection....Pages 81-89
Do neuronal inclusions kill the cell?....Pages 91-93
Mechanisms of cell death in neurodegenerative disorders....Pages 95-114
Estrogens, apoptosis and cells of neural origin....Pages 115-123
Markers of apoptosis and models of programmed cell death in Alzheimer’s disease....Pages 125-131
Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease....Pages 133-154
Genetics of Alzheimer’s disease — routes to the pathophysiology....Pages 155-161
Secretion of the amyloid precursor protein is elevated isoform specifically by apolipoprotein E4....Pages 163-169
Alterations in neurotrophins and neurotrophin receptors in Alzheimer’s disease....Pages 171-174
Genetically altered transgenic models of Alzheimer’s disease....Pages 175-183
Morphological substrates of mental dysfunction in Lewy body disease: an update....Pages 185-212
Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach....Pages 213-222
Understanding the role of estrogen on cognition and dementia....Pages 223-229
Present and future of Alzheimer therapy....Pages 231-242
Trials to slow progression and prevent disease onset....Pages 243-249
Epidemiologic clues to the causes and routes to prevention of Alzheimer disease....Pages 251-254
Post-transcription modulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived factors....Pages 255-261
A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neurons....Pages 263-272
Neurotrophic effects of Cerebrolysin ® in animal models of excitotoxicity....Pages 273-280
Cerebrolysin ® reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection....Pages 281-292
Clinical experience with Cerebrolysin®....Pages 293-300
Approach towards an integrative drug treatment of Alzheimer’s disease....Pages 301-313
Oral Cerebrolysin ® enhances brain alpha activity and improves cognitive performance in elderly control subjects....Pages 315-328